Merck KGaA
MKGAF
$145.36
-$2.55-1.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.79% | -0.56% | -2.19% | -2.82% | -2.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.79% | -0.56% | -2.19% | -2.82% | -2.97% |
| Cost of Revenue | 0.85% | 2.88% | 5.29% | 6.81% | 3.48% |
| Gross Profit | 0.76% | -2.83% | -6.91% | -8.72% | -6.97% |
| SG&A Expenses | 1.88% | -1.32% | -1.79% | -1.61% | -0.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -45.41% | 189.48% | 38.16% | -19.94% | 58.75% |
| Total Operating Expenses | -1.26% | 3.82% | 3.42% | 2.57% | 2.94% |
| Operating Income | 10.37% | -17.64% | -23.39% | -22.33% | -23.51% |
| Income Before Tax | 1.57% | -7.16% | -14.17% | -15.56% | -16.68% |
| Income Tax Expenses | 15.54% | -13.17% | -22.46% | -26.54% | -29.66% |
| Earnings from Continuing Operations | -1.63% | -5.55% | -11.91% | -12.50% | -13.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 17.79% | 41.20% | 51.52% | 16.61% | 19.12% |
| Net Income | -1.57% | -5.38% | -11.72% | -12.48% | -12.97% |
| EBIT | 10.37% | -17.64% | -23.39% | -22.33% | -23.51% |
| EBITDA | 7.57% | -9.94% | -14.59% | -13.95% | -15.07% |
| EPS Basic | -1.47% | -5.28% | -11.57% | -12.32% | -12.84% |
| Normalized Basic EPS | 10.45% | -11.66% | -17.71% | -18.98% | -19.88% |
| EPS Diluted | -1.39% | -5.36% | -11.65% | -12.39% | -12.91% |
| Normalized Diluted EPS | 10.45% | -11.66% | -17.71% | -18.98% | -19.88% |
| Average Basic Shares Outstanding | -0.11% | -0.11% | -0.17% | -0.17% | -0.14% |
| Average Diluted Shares Outstanding | -0.11% | -0.11% | -0.17% | -0.17% | -0.14% |
| Dividend Per Share | -0.99% | 5.37% | 5.37% | 5.37% | 5.37% |
| Payout Ratio | -0.10% | -0.06% | 0.00% | 0.36% | 0.41% |
